Who is sponsoring NCT04921592?

NCT04921592 is sponsored by Kessler Foundation.

What drugs are being tested in NCT04921592?

Interventions in NCT04921592: upper extremity stimulation.

What condition does NCT04921592 study?

NCT04921592 studies Spinal Cord Injuries.

Is NCT04921592 still recruiting?

NCT04921592 is currently recruiting now. Last updated 6 May 2025.

Last reviewed 2025-05-06 · How we verify

NCT04921592

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Upper Extremity Training for Chronic Cervical Spinal Cord Injury

Recruiting now NA Last updated 6 May 2025

What this trial tests

NA trial testing upper extremity stimulation in Spinal Cord Injuries in 36 participants. Currently enrolling.

Timeline

14 June 2021

Primary endpoint
15 June 2027

15 November 2027

Quick facts

Lead sponsor	Kessler Foundation
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	36
Start date	14 June 2021
Primary completion	15 June 2027
Estimated completion	15 November 2027
Sites	1 location across United States

Drugs / interventions tested

upper extremity stimulation

Conditions studied

Spinal Cord Injuries — all drugs for Spinal Cord Injuries →

Sponsor

Kessler Foundation

Who can join

18 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to understand how the combination of activity-based recovery training and targeted spinal cord transcutaneous stimulation (scTS) can improve participants' ability to use their hand, arms, and core.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Neuromodulation in Spinal Cord Injury Using Transcutaneous Spinal Stimulation-Mapping for a Blood Pressure Response: A Case Series.
Engel-Haber E, Bheemreddy A, Bayram MB, Ravi M, et al · · 2024 · cited 7× · PMID 39391052 · DOI 10.1089/neur.2024.0066
Combining Therapeutic Strategies to Treat the Injured Spinal Cord: A Translational Perspective.
Sherman BC, Schmidt Read M, Hoh DJ, Guest JD, et al · · 2025 · cited 2× · PMID 40929022 · DOI 10.1177/08977151251371710

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting

Other Kessler Foundation trials

Trials by the same sponsor.

NCT07168941 — Evaluation and Refinement of KF-STRIDE Into the Interview! · NA · not yet recruiting
NCT07159100 — tDCS for Cancer-Related Fatigue and Weakness · EARLY_PHASE1 · not yet recruiting
NCT06886152 — Spinal Stimulation and Gait Training to Improve Mobility in TBI · NA · not yet recruiting
NCT07073313 — Using Muscle Functional MRI to Study Spatial Muscle Activation Patterns in People With SCI · not yet recruiting
NCT06923293 — Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04921592 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kessler Foundation
Last refreshed: 6 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04921592.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing